Literature DB >> 9075613

Normotensive bilateral pheochromocytoma with Lindau disease: case report.

F Otsuka1, T Ogura, M Nakagawa, N Hayakawa, H Kataoka, T Oishi, H Makino.   

Abstract

A 46-year-old man was found to have numerous cerebellar hemangioblastomas on magnetic resonance imaging (MRI). He denied any symptoms and had no history of hypertension, but his family history was remarkable for a father who died of renal cell carcinoma. Computed tomography (CT) of the abdomen revealed bilateral adrenal pheochromocytomas with significant enhancement in the regions where 131I-metaiodobenzylguanidine (MIBG) had noticeably accumulated. Endocrinological examinations demonstrated high plasma and urine catecholamine concentrations which were very responsive to metoclopramide and glucagon loading tests, without a significant change in blood pressure. After resection of bilateral pheochromocytomas, he underwent an operation for the cerebellar tumors. Since pheochromocytomas associated with Lindau or von Hippel-Lindau (VHL) disease have a tendency to multiple occurrence in normotensive patients, we suggest that patients with a family history involving VHL lesions should undergo cranial MRI, abdominal CT, MIBG scintigraphy and endocrinological examinations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9075613     DOI: 10.1507/endocrj.43.719

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  2 in total

1.  A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy, Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography.

Authors:  Pelin Arıcan; Berna Okudan Tekin; Seniha Naldöken; Rıza Şefizade; Dilek Berker
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

2.  The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency.

Authors:  Ko Harada; Kosuke Kimura; Masaya Iwamuro; Tomohiro Terasaka; Yoshihisa Hanayama; Eisei Kondo; Eiko Hayashi; Tadashi Yoshino; Fumio Otsuka
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.